Clinical Trials in Pittsburgh

Showing 12941-12960 of 18,076 trials

Fracture (FX) Improvement With Teriparatide: FiX-IT Study

NCT01705587

This open label comparison study examines the hypothesis that teriparatide given immediately following repair of an atypical subtrochanteric or diaphyseal femoral shaft fracture will enhance healing and improve bone mineral density compared to delayed treatment (after six months) with teriparatide or no treatment with teriparatide (patients who refuse therapy or for whom teriparatide is contraindicated). Patients with up-front teriparatide in addition will have greater quality of life measures and less pain compared to those with delayed or no therapy.

OsteoporosisAtypical Femoral Fracture

Susan L. Greenspan13 participantsStarted Dec 2012

Pittsburgh, Pennsylvania, United States

TERMINATEDPhase 4< 1 mile

Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk

NCT00559988

The IMPACT Study will investigate the potential clinical benefit of the combined use of BIOTRONIK Home Monitoring (HM) technology and a predefined anticoagulation plan compared to conventional device evaluation and physician-directed anticoagulation in patients with implanted dual-chamber defibrillators or cardiac resynchronization therapy devices.

Atrial FibrillationAtrial FlutterStroke+2 more

Biotronik, Inc.2,718 participantsStarted Feb 2008

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • Anaheim, California, United States +77 more locations

Fracture (FX) Improvement With Teriparatide: FiX-IT Study

Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk

Find Trials by Condition in Pittsburgh

Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF

Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)

A Study to Evaluate the Effect of Camicinal on Gastroparesis Symptoms in Type 1 and 2 Diabetic Subjects With Gastroparesis

Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer

Safety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and Older

Dose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88 L265P Mutation

A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)

A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease

Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II

Open-Label Study in Diabetic Foot Ulcers (DFU), to Evaluate Safety of 0.03% DSC127 Topical Gel in Chronic Use

Vorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Relapsed Chronic Lymphocytic Leukemia, or Relapsed B Cell Non-Hodgkin's Lymphoma

A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes

Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers

An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability Deflazacort

Safety and Efficacy Trial of Testosterone Undecanoate

Use of Infliximab for the Treatment of Pemphigus Vulgaris

Comparison of Cervical Laminectomy to Laminoplasty

Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma